Pharma C Investments - Notice of AGM
RNS Number : 5541H
Pharma C Investments PLC
24 November 2022
 

24 November 2022

 

Pharma C Investments PLC
("Pharma C" or the "Company")

Notice of AGM

 

Pharma C Investments (AQSE: PCIL), an early-stage investor and venture builder in the medical cannabis industry with a particular focus on companies that provide ancillary products and services to the medicinal cannabis sectors, announces that further to the announcement of 18 November 2022, the Annual General Meeting will now be held at 11am on Tuesday 20th December at the offices of Hill Dickinson LLP. Notice will be posted to shareholders today and will also be available on the company's website.

 

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For further information please visit www.pharmacinvestments.com 

 

For additional information please contact:

 

Pharma C Investments


Gavin Sathianathan, Investment Strategy Director

gavin@pharmacinvestments.com

 

Novum Securities

 

(AQSE Corporate Adviser)

 

Tel: +44 207 399 9400

 

David Coffman

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXFELFMLEESEIF ]]>